Lords Call For UK Government To Secure A ‘Growth’ Pricing Deal With Pharma
Executive Summary
The House of Lords held a debate on the UK’s statutory drug pricing scheme as a way of drawing attention to the need for a voluntary price deal that can revive the international competitiveness of the life science industry.